October 16, 2021 14:15 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Kashmir: Two terrorists behind targetted killings of civilian, cop shot dead | US to reopen land and air borders to fully vaccinated foreign visitors from Nov 8 | Navjot Sidhu meets Rahul Gandhi amid Punjab Congress turmoil | Army officer, jawan critically injured in counter terror op in J&K's poonch district | 'Will follow whatever Gandhis decide:' Navjot Sidhu after meeting senior Cong leaders amid Punjab crisis
Covaxin overall 77.8% effective against COVID-19, claims Bharat Biotech Covaxin
Image tweeted by @IndianEmbassyTR

Covaxin overall 77.8% effective against COVID-19, claims Bharat Biotech

IBNS | @indiablooms | 03 Jul 2021, 01:24 pm

New Delhi/IBNS: Hyderabad-based biotechnology company Bharat Biotech has claimed its anti-COVID-19 vaccine, Covaxin, is 77.8% effective against the deadly virus.

Bharat Biotech made the claim in the phase three clinical trial data of the vaccine.

The company has further claimed Covaxin is 93.4% effective against severe symptomatic COVID-19 cases, 63.6% against asymptomatic COVID-19 cases and 65.2% against the Delta variant.

Bharat Biotech co-founder Suchitra Ella tweeted, "We are proud to put India on the global map with scientific conviction,competence & commitment. #Covaxin scores #10 world class publications endorsing Innovation, clinical research,data,safety, efficacy. Thanq collaborators & Positive BB teamwork enduring a pandemic."

At present four anti-COVID-19 vaccines including Covaxin have been permitted by the central government to be used in the vaccination drive.

Apart from Covaxin, three other vaccines are AstraZeneca's Indian version Covishield, Russia's Sputnik and US-made Moderna.